Postprandial plasma phospholipids in men are influenced by the source of dietary fat

Journal of Nutrition

Volumn 145, Issue 9, 2015, Pages 2012-2018

  Meikle, Peter J ^a   Barlow, Christopher K ^a   Mellett, Natalie A ^a   Mundra, Piyushkumar A ^a   Bonham, Maxine P ^b,c   Larsen, Amy ^b,d   Cameron Smith, David ^b,e   Sinclair, Andrew ^b   Nestel, Paul J ^a   Wong, Gerard ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b DEAKIN UNIVERSITY   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d LA TROBE UNIVERSITY   (Australia)

^e UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Dairy; Humans; Lipidomics; Mass spectrometry; Phospholipids; Soy

Indexed keywords

ACYLGLYCEROL; ALKENYLPHOSPHATIDYLCHOLINE; ALKENYLPHOSPHATIDYLETHANOLAMINE; ALKYLPHOSPHATIDYLCHOLINE; ALKYLPHOSPHATIDYLETHANOLAMINE; CERAMIDE DERIVATIVE; CHOLESTEROL; CHOLESTEROL ESTER; DIACYLGLYCEROL; DIHEXOSYLCERAMIDE; DIHYDROCERAMIDE; GANGLIOSIDE GM3; LIPIDOME; LYSOALKYLPHOSPHATIDYLCHOLINE; LYSOPHOSPHATIDYLCHOLINE; LYSOPHOSPHATIDYLETHANOLAMINE; LYSOPHOSPHATIDYLINOSITOL; MONOHEXOSYLCERAMIDE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLGLYCEROL; PHOSPHATIDYLINOSITOL; PHOSPHOETHANOLAMINE; PHOSPHOLIPID; PHOSPHORYLCHOLINE; PLASMALOGEN; SPHINGOMYELIN; TRIACYLGLYCEROL; TRIHEXOSYLCERMIDE; UNCLASSIFIED DRUG; FAT INTAKE; FATTY ACID; GLUCOSE BLOOD LEVEL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; ELECTROSPRAY MASS SPECTROMETRY; FAT INTAKE; FRIEDMAN TEST; HUMAN; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; PHOSPHOLIPID BLOOD LEVEL; POSTPRANDIAL STATE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SOYBEAN MEAL; TANDEM MASS SPECTROMETRY; TRIACYLGLYCEROL BLOOD LEVEL; WILCOXON SIGNED RANKS TEST; ADMINISTRATION AND DOSAGE; BLOOD; COMPLICATION; DAIRY PRODUCT; DIET; GLUCOSE BLOOD LEVEL; HYPERLIPIDEMIA; MEAL; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; SOY FOOD;

ADULT; BLOOD GLUCOSE; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-OVER STUDIES; DAIRY PRODUCTS; DIABETES MELLITUS, TYPE 2; DIET; DIETARY FATS; FATTY ACIDS; HUMANS; HYPERLIPIDEMIAS; INSULIN; MALE; MEALS; MIDDLE AGED; PHOSPHOLIPIDS; POSTPRANDIAL PERIOD; RETROSPECTIVE STUDIES; SOY FOODS; TRIGLYCERIDES;

EID: 84941095173     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.115.210104     Document Type: Article

References (41)

1. Meikle PJ, Wong G, Barlow CK, Kingwell BA. Lipidomics: potential role in risk prediction and therapeutic monitoring for diabetes and cardiovascular disease. Pharmacol Ther 2014;143: 12-23.
2. Meikle PJ, Wong G, Barlow CK, Weir JM, Greeve MA, Macintosh GL, Almasy L, Comuzzie AG, Mahaney MC, Kowalczyk A, et al. Plasma lipid profiling shows similar associations with prediabetes and type 2 diabetes. PLoS One 2013;8:e74341.
3. Meikle PJ, Wong G, Tsorotes D, Barlow CK, Weir JM, Christopher MJ, MacIntosh GL, Goudey B, Stern L, Kowalczyk A, et al. Plasma lipidomic analysis of stable and unstable coronary artery disease. Arterioscler Thromb Vasc Biol 2011;31:2723-32.
4. Stahlman M, Fagerberg B, Adiels M, Ekroos K, Chapman JM, Kontush A, Boren J. Dyslipidemia, but not hyperglycemia and insulin resistance, is associated with marked alterations in the HDL lipidome in type 2 diabetic subjects in the DIWA cohort: impact on small HDL particles. Biochim Biophys Acta 2013;1831:1609-17.
5. Stegemann C, Pechlaner R, Willeit P, Langley SR, Mangino M, Mayr U, Menni C, Moayyeri A, Santer P, Rungger G, et al. Lipidomics profiling and risk of cardiovascular disease in the prospective population-based Bruneck study. Circulation 2014;129:1821-31.
6. Weir JM, Wong G, Barlow CK, Greeve MA, Kowalczyk A, Almasy L, Comuzzie AG, Mahaney MC, Jowett JB, Shaw J, et al. Plasma lipid profiling in a large population-based cohort. J Lipid Res 2013;54: 2898-908.
7. Tushuizen ME, Pouwels PJ, Bontemps S, Rustemeijer C, Matikainen N, Heine RJ, Taskinen MR, Diamant M. Postprandial lipid and apolipoprotein responses following three consecutive meals associate with liver fat content in type 2 diabetes and the metabolic syndrome. Atherosclerosis 2010; 211:308-14.
8. Groot PH, van Stiphout WA, Krauss XH, Jansen H, van Tol A, van Ramshorst E, Chin-On S, Hofman A, Cresswell SR, Havekes L. Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler Thromb 1991;11:653-62.
9. Patsch JR, Miesenbock G, Hopferwieser T, Muhlberger V, Knapp E, Dunn JK, Gotto AM, Jr., Patsch W. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb 1992;12:1336-45.
10. Varbo A, Benn M, Tybjaerg-Hansen A, Jorgensen AB, Frikke-Schmidt R, Nordestgaard BG. Remnant cholesterol as a causal risk factor for ischemic heart disease. J Am Coll Cardiol 2013;61:427-36.
11. Holmes MV, Asselbergs FW, Palmer TM, Drenos F, Lanktree MB, Nelson CP, Dale CE, Padmanabhan S, Finan C, Swerdlow DI, et al. Mendelian randomization of blood lipids for coronary heart disease. Eur Heart J 2015;36:539-50.
12. Do R, Willer CJ, Schmidt EM, Sengupta S, Gao C, Peloso GM, Gustafsson S, Kanoni S, Ganna A, Chen J, et al. Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat Genet 2013;45:1345-52.
13. Riccardi G, Bozzetto L, Annuzzi G. Postprandial lipid metabolism. Scand J Food Nutr 2006;50:99-106.
14. Burdge GC, Powell J, Calder PC. Lack of effect of meal fatty acid composition on postprandial lipid, glucose and insulin responses in men and women aged 50-65 years consuming their habitual diets. Br J Nutr 2006;96:489-500.
15. Soedamah-Muthu SS, Ding EL, Al-Delaimy WK, Hu FB, Engberink MF, Willett WC, Geleijnse JM. Milk and dairy consumption and incidence of cardiovascular diseases and all-cause mortality: dose-response meta-analysis of prospective cohort studies. Am J Clin Nutr 2011;93: 158-71.
16. Vessby B, Uusitupa M, Hermansen K, Riccardi G, Rivellese AA, Tapsell LC, Nalsen C, Berglund L, Louheranta A, Rasmussen BM, et al. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: the KANWU study. Diabetologia 2001;44: 312-9.
17. Kim J. Dairy food consumption is inversely associated with the risk of the metabolic syndrome in Korean adults. J Hum Nutr Diet 2013;26 Suppl 1:171-9.
18. Fumeron F, Lamri A, Abi Khalil C, Jaziri R, Porchay-Balderelli I, Lantieri O, Vol S, Balkau B, Marre M; Data from the Epidemiological Study on the Insulin Resistance Syndrome Study Group. Dairy consumption and the incidence of hyperglycemia and the metabolic syndrome: results from a French prospective study, Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 2011;34:813-7.
19. Azadbakht L, Mirmiran P, Esmaillzadeh A, Azizi F. Dairy consumption is inversely associated with the prevalence of the metabolic syndrome in Tehranian adults. Am J Clin Nutr 2005;82:523-30.
20. Bonham MP, Linderborg KM, Dordevic A, Larsen AE, Nguo K, Weir JM, Gran P, Luotonen MK, Meikle PJ, Cameron-Smith D, et al. Lipidomic profiling of chylomicron triacylglycerols in response to high fat meals. Lipids 2013;48:39-50.
21. Fahy E, Subramaniam S, Murphy RC, Nishijima M, Raetz CR, Shimizu T, Spener F, van Meer G, Wakelam MJ, Dennis EA. Update of the LIPID MAPS comprehensive classification system for lipids. J Lipid Res 2009;50 Suppl:S9-14.
22. Liebisch G, Vizcaino JA, Kofeler H, TrotzmullerM, GriffithsWJ, Schmitz G, Spener F, WakelamMJ. Shorthand notation for lipid structures derived from mass spectrometry. J Lipid Res 2013;54:1523-30.
23. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 1995;57:289-300.
24. Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 2007;298:299-308.
25. Pollin TI, Damcott CM, Shen H, Ott SH, Shelton J, Horenstein RB, Post W, McLenithan JC, Bielak LF, Peyser PA, et al. A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection. Science 2008;322:1702-5.
26. Scott R, O'Brien R, Fulcher G, Pardy C, D'Emden M, Tse D, Taskinen MR, Ehnholm C, Keech A, Fenofibrate I, et al. Effects of fenofibrate treatment on cardiovascular disease risk in 9, 795 individuals with type 2 diabetes and various components of the metabolic syndrome: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetes Care 2009;32:493-8.
27. Riccardi G, Capaldo B, Vaccaro O. Functional foods in the management of obesity and type 2 diabetes. Curr Opin Clin Nutr Metab Care 2005;8:630-5.
28. Demacker PN, Reijnen IG, Katan MB, Stuyt PM, Stalenhoef AF. Increased removal of remnants of triglyceride-rich lipoproteins on a diet rich in polyunsaturated fatty acids. Eur J Clin Invest 1991;21:197-203.
29. Weintraub MS, Zechner R, Brown A, Eisenberg S, Breslow JL. Dietary polyunsaturated fats of the W-6 and W-3 series reduce postprandial lipoprotein levels. Chronic and acute effects of fat saturation on postprandial lipoprotein metabolism. J Clin Invest 1988;82:1884-93.
30. Chung BH, Cho BH, Liang P, Doran S, Osterlund L, Oster RA, Darnell B, Franklin F. Contribution of postprandial lipemia to the dietary fatmediated changes in endogenous lipoprotein-cholesterol concentrations in humans. Am J Clin Nutr 2004;80:1145-58.
31. Karupaiah T, Sundram K. Modulation of human postprandial lipemia by changing ratios of polyunsaturated to saturated (P/S) fatty acid content of blended dietary fats: a cross-over design with repeated measures. Nutr J 2013;12:122.
32. Contarini G, Povolo M. Phospholipids in milk fat: composition, biological and technological significance, and analytical strategies. Int J Mol Sci 2013;14:2808-31.
33. Scholfield CR. Composition of soybean lecithin. J Am Oil Chem Soc 1981;58:889-92.
34. Iqbal J, Hussain MM. Intestinal lipid absorption. Am J Physiol Endocrinol Metab 2009;296:E1183-94.
35. Lemaitre-Delaunay D, Pachiaudi C, Laville M, Pousin J, Armstrong M, Lagarde M. Blood compartmental metabolism of docosahexaenoic acid (DHA) in humans after ingestion of a single dose of [(13)C]DHA in phosphatidylcholine. J Lipid Res 1999;40:1867-74.
36. Pineiro R, Falasca M. Lysophosphatidylinositol signalling: new wine from an old bottle. Biochim Biophys Acta 2012;1821:694-705.
37. Moreno-Navarrete JM, Catalan V, Whyte L, Diaz-Arteaga A, Vazquez-Martinez R, Rotellar F, Guzman R, Gomez-Ambrosi J, Pulido MR, Russell WR, et al. The L-alpha-lysophosphatidylinositol/GPR55 system and its potential role in human obesity. Diabetes 2012;61:281-91.
38. AlSuleimani YM, Hiley CR. The GPR55 agonist lysophosphatidylinositol relaxes rat mesenteric resistance artery and induces Ca(2+) release in rat mesenteric artery endothelial cells. Br J Pharmacol 2015; 172:3043-57.
39. Kargl J, Brown AJ, Andersen L, Dorn G, Schicho R, Waldhoer M, Heinemann A. A selective antagonist reveals a potential role of G protein-coupled receptor 55 in platelet and endothelial cell function. J Pharmacol Exp Ther 2013;346:54-66.
40. Reis A, Rudnitskaya A, Chariyavilaskul P, Dhaun N, Melville V, Goddard J, Webb DJ, Pitt AR, Spickett CM. Top-down lipidomics of low density lipoprotein reveal altered lipid profiles in advanced chronic kidney disease. J Lipid Res 2015;56:413-22.
41. Nestel PJ, Mellett N, Pally S, Wong G, Barlow CK, Croft K, Mori TA, Meikle PJ. Effects of low-fat or full-fat fermented and non-fermented dairy foods on selected cardiovascular biomarkers in overweight adults. Br J Nutr 2013;110:2242-9.